Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Core Laboratories (CLB) EPS (Weighted Average and Diluted) (2022 - 2025)

Core Laboratories (CLB) has 4 years of EPS (Weighted Average and Diluted) data on record, last reported at $0.29 in Q3 2025.

  • For Q3 2025, EPS (Weighted Average and Diluted) rose 16.0% year-over-year to $0.29; the TTM value through Sep 2025 reached $0.68, up 21.43%, while the annual FY2024 figure was $0.67, 14.1% down from the prior year.
  • EPS (Weighted Average and Diluted) reached $0.29 in Q3 2025 per CLB's latest filing, up from $0.23 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $0.48 in Q2 2023 and bottomed at $0.05 in Q1 2023.
  • Average EPS (Weighted Average and Diluted) over 4 years is $0.19, with a median of $0.18 recorded in 2024.
  • The widest YoY moves for EPS (Weighted Average and Diluted): up 220.0% in 2023, down 66.67% in 2023.
  • A 4-year view of EPS (Weighted Average and Diluted) shows it stood at $0.15 in 2022, then crashed by 66.67% to $0.05 in 2023, then soared by 220.0% to $0.16 in 2024, then skyrocketed by 81.25% to $0.29 in 2025.
  • Per Business Quant database, its latest 3 readings for EPS (Weighted Average and Diluted) were $0.29 in Q3 2025, $0.23 in Q2 2025, and $0.16 in Q4 2024.